<DOC>
	<DOCNO>NCT00001071</DOCNO>
	<brief_summary>To determine safety stem cell harvest administration filgrastim ( G-CSF ) mobilize bone marrow stem cell peripheral blood patient various stage HIV-1 infection well HIV-negative volunteer . To determine surface phenotypic functional characteristic well viral load stem cell obtain follow procedure .</brief_summary>
	<brief_title>A Study Stem Cells Filgrastim</brief_title>
	<detailed_description>Patients volunteer receive seven daily subcutaneous injection G-CSF . On day 5 6 drug administration , patient peripheral blood mononuclear cell harvest leukapheresis . HIV-positive patient stratify three cohort base CD4 count presence symptom . If increase number harvest stem cell grade 4 bone pain toxicity occur two first three patient cohort , last three patient cohort receive dose escalation . Patients follow 24 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : PCP prophylaxis . Antiretroviral therapy patient CD4 count &lt; = 500 cells/mm3 . Narcotic analgesic grade 3/4 bone pain toxicity . Patients must : HIV infection . HIV infect patient CD4 count &gt; 500 cells/mm3 must asymptomatic . Patients CD4 count 200500 cells/mm3 may either asymptomatic symptomatic must AIDS . Patients CD4 count &lt; 200 cells/mm3 may may AIDSdefining condition . No antiretroviral therapy within past 30 day patient asymptomatic disease CD4 count &gt; 500 cells/mm3 . Stable antiretroviral therapy past 60 day CD4 count &lt; = 500 cells/mm3 . Suitable venous access . Prior Medication : Allowed : Prior antiretroviral therapy . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Current malignancy . Any medication condition interferes study evaluation . Known hypersensitivity E. coliderived protein ( e.g. , insulin , human growth hormone ) . Concurrent Medication : Excluded : Acute treatment serious opportunistic infection . Systemic cytotoxic chemotherapy . Concurrent Treatment : Excluded : Systemic radiation therapy . Patients follow prior condition exclude : Prior malignancy . Leukapheresis lymphopheresis within past 180 day . Significant active CNS disease seizure within past year . Prior Medication : Excluded : GCSF GMCSF within past 6 month . Investigational antiretrovirals within past 30 day . Treatment opportunistic infection within past 14 day . Active alcohol substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Granulocyte Colony-Stimulating Factor</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Stem Cells</keyword>
</DOC>